openPR Logo
Press release

North America Injectable Drug Delivery Market to Observe Strong Development of 13.0% CAGR by 2023 | Top Key Players - Antares Pharma, Baxter, Elcam Medical, Eli Lilly, Unilife

09-27-2018 06:30 PM CET | Health & Medicine

Press release from: Market Prognosis

Injectable Drug Delivery Market

Injectable Drug Delivery Market

Marketprognosis.com Publish a New Market Research Report On “North America Injectable Drug Delivery Market 2018 - 2023” which contains North America key player’s survey information and forecast to 2023.

Overview of the North America Injectable Drug Delivery Market:

The North America Injectable Drug Delivery Market is expected to register a CAGR of over 13.0% during the forecast period of 2018 - 2023.

Injectable drug delivery technologies allow the transport of drugs formulated in liquid form and facilitate the rapid transport of the drug into the body. It also helps in administering drugs in unconscious and comatose patients. These delivery systems are widely accepted due to their advantage of a faster onset of action with high efficacy. Also, in recent years, this market has grown due to the increased prevalence of cancer and diabetes.

Get a Sample Copy of this Report @ https://marketprognosis.com/sample-request/16861 .

Some of the most common chronic diseases include heart disease, stroke, type 2 diabetes, obesity, cancer, and arthritis. According to the Center for Disease Control and Prevention (CDC), in the United States, seven of the top 10 causes of death in 2014 were chronic diseases. Cancer and heart disease together accounted for an approximate of 46% of all deaths. It was also reported that about half of the adults in the United States had one or more chronic conditions and one if four had more than two chronic conditions. Moreover, these numbers are expected to increase in the next 10 years. Since the adoption rate of injectable drug delivery devices is high among the population suffering from diseases like diabetes and heart-related disorders, the increasing prevalence of chronic diseases is expected to contribute to the growth of injectable drug delivery technology market in the forecast period.

Injuries and infections due to needles are acting as a major restraint for the global injectable drug delivery technology market. According to the Occupational Safety & Health Administration (OSHA) estimates, 5.6 million workers in the healthcare industry are at a risk of needle injuries. Moreover, there has been an increment in the infections caused by needles over the past few years. Therefore with the increasing injuries and the infections caused by needles, there is reluctance among people to use injections, hampering the growth of the injectable drug delivery technology market.

Purchase this report online with 86 Pages, Top Key Players Analysis and List of Tables & Figure @ https://marketprognosis.com/buyReport/16861 .

The United States injectable drug delivery technology market held the largest market share in 2017 in North America due to the rising incidence of cardiovascular diseases, growing geriatric population, and the strong presence of industry players in that region.

Major Key Players:

1 Antares Pharmaceutical Inc.

2 Baxter International

3 Becton, Dickinson, and Company

4 Elcam Medical

5 Eli Lilly and Company

6 Unilife Corporation

7 West Pharmaceutical Services Inc.

Any Query? Ask to our Expert @ https://marketprognosis.com/enquiry/16861 .

What Information does this report contain?

1 A detailed analysis of regulatory trends, drivers, industry pitfalls, challenges and growth opportunities for participants

2 Which are the leading market products, applications & regions and how will they perform by 2023?

3 What are the technologies & innovation trends, how will they evolve by 2023?

4 Which companies lead the industry, how are they positioned in the market in terms of sustainability, competency, production capacity and strategic outlook?

In the end, this report covers data and information on capacity and production overview, production, market share analysis, sales overview, supply, sales, and shortage, import, export and consumption as well as cost, price, revenue and gross margin of Injectable Drug Delivery Market.

Table of Contents:

1 Introduction

2 Research Methodology

3 Executive Summary

4 Key Inferences

5 Market Overview

6 Drivers, Restraints, Opportunities and Challenges Analysis (Droc)

7 Market Segmentation

8 Competitive Landscape

9 Key Players

10 Future Outlook of the Market

About us:

We at Market Prognosis believe in giving a crystal clear view of market dynamics for achieving success in today’s complex and competitive marketplace through our quantitative & qualitative research methods.
We help our clients identify the best market insights and analysis required for their business thus enabling them to take strategic and intelligent decision.
We believe in delivering actionable insights for your business growth and success.

ProgMark Pvt. Ltd.
Thane – 421501
India.

sales@marketprognosis.com
+1 973 241 5193
https://www.marketprognosis.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release North America Injectable Drug Delivery Market to Observe Strong Development of 13.0% CAGR by 2023 | Top Key Players - Antares Pharma, Baxter, Elcam Medical, Eli Lilly, Unilife here

News-ID: 1268119 • Views:

More Releases from Market Prognosis

Third-Party Logistics (3PL) Market Latest Study Focuses On Current, Future Innovations and Foreseen Till 2026 | FedEx, Exel Logistics, Menlo Worldwide Logistics, Ryder Logistics
Third-Party Logistics (3PL) Market Latest Study Focuses On Current, Future Innov …
The report covers a forecast and an analysis of the Third-Party Logistics (3PL) Market on a global and regional level. The study provides historical data for 2018, 2019, and 2020 along with a forecast from 2019 to 2026 based on revenue and volume. Overview of the Global Third-Party Logistics (3PL) Market: The report spread across 90 pages is an overview of the Global Third-Party Logistics (3PL) Market. These report study based on the Third-Party
Ride-Hailing Market: An Insight on the Important Factors and Trends Influencing by Top Key Players (Didi, Uber, Lyft, Gett, Hailo, Ola Cabs, Cabify, GoCatch) | Foreseen Till 2026
Ride-Hailing Market: An Insight on the Important Factors and Trends Influencing …
The report covers a forecast and an analysis of the Ride-Hailing Market on a global and regional level. The study provides historical data for 2018, 2019, and 2020 along with a forecast from 2019 to 2026 based on revenue and volume. Overview of the Global Ride-Hailing Market: The report spread across 90 pages is an overview of the Global Ride-Hailing Market. These report study based on the Ride-Hailing Market. It is a complete overview
COVID-19 Impact on Professional Indemnity Insurance Market 2021-2026: Industry Insight and Growth Strategy by Business Players - AIG, Chubb (ACE), Allianz, XL Group, AXA, Aviva
COVID-19 Impact on Professional Indemnity Insurance Market 2021-2026: Industry I …
The report covers a forecast and an analysis of the Professional Indemnity Insurance Market on a global and regional level. The study provides historical data for 2018, 2019, and 2020 along with a forecast from 2019 to 2026 based on revenue and volume. Overview of the Global Professional Indemnity Insurance Market: The report spread across 90 pages is an overview of the Global Professional Indemnity Insurance Market. These report study based on the Professional
Modular Construction Market Future Growth Explored in Latest Research Report by 2026 | Komatsu, Kiewit, Skanska, L&T, Taisei, ACS Group, Bouygues Construction
Modular Construction Market Future Growth Explored in Latest Research Report by …
The report covers a forecast and an analysis of the Modular Construction Market on a global and regional level. The study provides historical data for 2018, 2019, and 2020 along with a forecast from 2019 to 2026 based on revenue and volume. Overview of the Global Modular Construction Market: The report spread across 90 pages is an overview of the Global Modular Construction Market. These report study based on the Modular Construction Market. It

All 5 Releases


More Releases for Injectable

Key Small Molecule Injectable Drugs Market Trend for 2025-2034: Small Molecule I …
What Is the Future Outlook for the Small Molecule Injectable Drugs Market's Size and Growth Rate? The small molecule injectable drugs market has grown rapidly in recent years. It will rise from $219.57 billion in 2024 to $248.2 billion in 2025, at a CAGR of 13.0%. The growth is attributed to the rising prevalence of chronic diseases, an aging population, government initiatives, increased healthcare spending, and improvements in manufacturing processes. The small
Injectable Drug Delivery Market Injectable Drug Delivery Market
Leading market research firm SkyQuest Technology Group recently released a study titled ' Injectable Drug Delivery Market Global Size, Share, Growth, Industry Trends, Opportunity and Forecast 2024-2031,' This study Injectable Drug Delivery report offers a thorough analysis of the market, as well as competitor and geographical analysis and a focus on the most recent technological developments. The research study on the Injectable Drug Delivery Market extensively demonstrates existing and upcoming
Facial Injectable Market Size to Hit $7.5 Billion by 2028 | Facial Injectable In …
According to our experience research team, Facial Injectable Market was valued at USD 4.4 Billion in 2021, and the global Facial Injectable industry is projected to reach a value of USD 7.5 Billion by 2028, at a CAGR of 9.4% during the forecast period 2022-2028 The report is focused on gaining various Facial Injectable market trends, dynamics, growth drivers, opportunities, weaknesses, strengths, and threats restraining the market growth. Further, the global
Small-Molecule Injectable Market
The global Small-Molecule Injectable Market was valued at US$ 55.8 Bn in 2020. Expanding at a 7.3% CAGR, the market valuation is expected to top US$ 112.9 Bn by 2031, finds ESOMAR-certified consulting firm Future Market Insights (FMI) in a recent market analysis. The COVID-19 pandemic outbreak has sparked efforts to repurpose already-approved medicines for treatment. Several clinical studies are now being conducted on different antiviral medicines and small-molecule injectables that
Global Injectable Drug Delivery Devices Market | Global Injectable Drug Delivery …
The injectable drug delivery devices market involves of sales of conventional syringes, needle-free injectors, auto injectors and pen injectors. The market contains the sales of the Injectable devices that have been comprehensively utilized for several routes of drug administration, such as intravenous, subcutaneous, intradermal, intra-peritoneal, and intra-muscular and several others to cure the medical conditions vacillating from cancer to autoimmune disorders. The injectable drug delivery devices utilized in hospitals, clinics
Ioversol Market Report 2018: Segmentation by Type (Ioversol 34% Injectable Solut …
Global Ioversol market research report provides company profile for China Resources Pharmaceutical (Shanghai) Co, HB Ocean, Novalek Pharmaceuticals Pvt. Ltd, Stellence Pharmscience Pvt. Ltd, A.S. Joshi & Company, Liebel-Flarsheim Company LLC, Guerbet, Jiangsu Hengrui Medicine Co, Mallinckrodt Pharmaceuticals, Ultraject and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of